Edith Sanford Breast Cancer Research

Translational Genomics Network

Edith Sanford Breast Cancer research at Sanford Research is pursuing cutting-edge forward genomic research to identify specific treatments that will work best for each woman, prevent the disease on an individual basis, and ultimately eradicate breast cancer. As part of Sanford Health, the largest rural non-profit health care system in the nation, we can integrate research and patient care so that information flows seamlessly— translational genomic research discoveries are accelerated into clinical applications, such as new treatments and diagnostics to benefit patients, and clinical data about patient response flows back to the labs to inform more discoveries.
 

Edith Sanford Breast Cancer Research Team


James Ford, MD
National Genomic Oncology Advisor, Edith Sanford Breast Cancer Center

Dr. Ford advises Edith Sanford Breast Cancer research on clinical research and personalized treatments for breast cancer. He is currently an associate professor of medicine (oncology) and genetics and director of the Stanford Cancer Genetics Clinic and the Cancer Genomics Program at Stanford University Medical Center.

Dr. Ford graduated from Yale University in 1984 and received his medical degree from the Yale School of Medicine in 1989. The recipient of numerous national awards, Dr. Ford is also an editor for Cancer Research, PLoS Genetics and DNA Repair and serves on the scientific review committee for the V Foundation for Cancer Research.
 

Eugene H. Hoyme, MD
Chief of Genetics and Genomic Medicine, Sanford Health

Dr. Hoyme is a board-certified geneticist and pediatrician. He currently serves as chief of genetics and genomic medicine and chief academic officer for Sanford Health. He is also a professor of pediatrics (medical genetics) at the Sanford School of Medicine of the University of South Dakota. From 2011-2014 he served as president of Sanford Research, and from 2007-2011 he served as chair of the Department of Pediatrics of the Sanford School of Medicine. Previously, he held academic appointments and leadership posts at the Stanford School of Medicine, Palo Alto, the University of Arizona College of Medicine, Tucson, and the University of Vermont College of Medicine, Burlington.  

Dr. Hoyme has held numerous leadership roles in regional and national clinical and research organizations in pediatrics and medical genetics. He has authored 140 original articles and 25 book chapters, monographs and electronic publications. He is the co-author of Signs and Symptoms of Genetic Disease, a 2014 textbook published by Oxford University Press.
 

David Pearce, PhD
President, Sanford Research

Dr. Pearce is the president of Sanford Research, home of Edith Sanford Breast Cancer Research. He is the former vice president and chief operating officer of Sanford Research and played a critical role in establishing the Edith Sanford Breast Cancer Research program and Sanford Health BioBank. Dr. Pearce is also the director of the Sanford Children’s Health and Research Center. 

Dr. Pearce also heads the leading lab in juvenile Batten disease research. He has been researching juvenile neuronal ceroid lipofuscinosis (Batten disease) since 1997. He is responsible for the establishment of the Batten Disease Diagnostic and Clinical Research Center at the University of Rochester School of Medicine.

He completed his undergraduate bachelor of science degree with honors in Biological Sciences at Wolverhampton Polytechnic in 1986. He gained his PhD in 1990 at the University of Bath, UK, and did postdoctoral training at the University of Rochester and Oxford University, UK.
 

Chun-hung Chan, PhD
Director, Edith Sanford BioBank at Sanford Health

Dr. Chan oversees all sample processing, biobanking, and genomic sequencing operations at Sanford Health, which supports key research initiatives in breast cancer, genetic disorders and rare disease. Dr. Chan received a PhD in developmental neurobiology at University College London and his bachelor of science in biochemistry at the University of Bath in the United Kingdom. His postdoctoral fellowship was completed at the University of Rochester School of Medicine.